Post-transplant immunosuppressive drug infusions and donor pretreatment

The new chimaera: the industrialization of organ transplantation. International Forum for Transplant Ethics.

Transplantation·2001

Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1998

Definitions of acute rejection and controlled clinical trials in the medical literature.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1998

Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference.

Transplantation·1998

Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression.

Transplantation proceedings·1997

Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.

Clinical transplantation·1997

HPV-associated Anal Dysplasia in Solid Organ Transplant Recipients: A Transplant-specific Model of Mucosal Immune Dysfunction.

Transplantation·2026

Cancer Risk in Kidney Transplant Recipients on Belatacept Versus Calcineurin Inhibitors: A Systematic Review and Meta-Analysis.

Transplantation·2026

Neurocognitive Recovery After Liver Transplantation Is Driven by Metabolite-mediated Reactivation of Cortical Networks.

Transplantation·2026

Survival Benefit Tradeoff: When a Lower KDPI Kidney Does Not Outweigh the Risks of Waiting.

Transplantation·2026

Urinary Extracellular Vesicles as a Source of Biomarkers for Kidney Allograft Rejection: A Systematic Review.

Transplantation·2026

Donor Kidney Assessment-Functional Metrics and Biomarkers During Ex Situ Machine Perfusion.

Transplantation·2026

Subcutaneous Alemtuzumab as Salvage Therapy for Acute Kidney Transplant Rejection Following Thymoglobulin Anaphylaxis: A Pediatric Case Report.

Pediatric transplantation·2026

Impella 5.5 as a bridge to dual-organ transplantation.

The International journal of artificial organs·2026

The role of heparanase in organ allograft rejection and the effect of heparanase inhibition on allograft survival.

Transplant immunology·2026

Outcomes of ABO-Incompatible Versus ABO-Compatible Liver Transplantation in Pediatric Recipients: An Updated Systematic Review and Meta-Analysis.

Pediatric transplantation·2026

Associations of IL-2, IL-6 and IL-10 Gene Polymorphisms with Biochemical Parameters and Calcineurin Inhibitor Dosing in Kidney Transplant Recipients.

Biomedicines·2026

Surviving Without Nerves: Intracardiac Denervation as an Underrecognized Feature of Cardiac Allograft Vasculopathy and Chronic Graft Dysfunction: A Morphological Case Report 11 Years After Transplantation.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Videos

Post-transplant immunosuppressive drug infusions and donor pretreatment

Related Concept Videos

The new chimaera: the industrialization of organ transplantation. International Forum for Transplant Ethics.

Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection.

Definitions of acute rejection and controlled clinical trials in the medical literature.

Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference.

Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression.

Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.

HPV-associated Anal Dysplasia in Solid Organ Transplant Recipients: A Transplant-specific Model of Mucosal Immune Dysfunction.

Cancer Risk in Kidney Transplant Recipients on Belatacept Versus Calcineurin Inhibitors: A Systematic Review and Meta-Analysis.

Neurocognitive Recovery After Liver Transplantation Is Driven by Metabolite-mediated Reactivation of Cortical Networks.

Survival Benefit Tradeoff: When a Lower KDPI Kidney Does Not Outweigh the Risks of Waiting.

Urinary Extracellular Vesicles as a Source of Biomarkers for Kidney Allograft Rejection: A Systematic Review.

Donor Kidney Assessment-Functional Metrics and Biomarkers During Ex Situ Machine Perfusion.

Subcutaneous Alemtuzumab as Salvage Therapy for Acute Kidney Transplant Rejection Following Thymoglobulin Anaphylaxis: A Pediatric Case Report.

Impella 5.5 as a bridge to dual-organ transplantation.

The role of heparanase in organ allograft rejection and the effect of heparanase inhibition on allograft survival.

Outcomes of ABO-Incompatible Versus ABO-Compatible Liver Transplantation in Pediatric Recipients: An Updated Systematic Review and Meta-Analysis.

Associations of IL-2, IL-6 and IL-10 Gene Polymorphisms with Biochemical Parameters and Calcineurin Inhibitor Dosing in Kidney Transplant Recipients.

Surviving Without Nerves: Intracardiac Denervation as an Underrecognized Feature of Cardiac Allograft Vasculopathy and Chronic Graft Dysfunction: A Morphological Case Report 11 Years After Transplantation.

Related Experiment Videos

Post-transplant immunosuppressive drug infusions and donor pretreatment

Related Concept Videos

Related Articles